POLYMORPHIC DRUG OXIDATION - PHARMACOKINETIC BASIS AND COMPARISON OF EXPERIMENTAL INDEXES

被引：76

作者：

JACKSON, PR ^{[1
]}

TUCKER, GT ^{[1
]}

LENNARD, MS ^{[1
]}

WOODS, HF ^{[1
]}

机构：

[1] UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT THERAPEUT,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 22卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1986.tb02933.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：541 / 550

页数：10

相关论文

共 21 条

[1] ANGELO M, 1975, BRIT J PHARMACOL, V55, pP264
[2] GAUSSIAN PSEUDO-RANDOM NUMBER GENERATOR
BRENT, RP
[J]. COMMUNICATIONS OF THE ACM, 1974, 17 (12) : 704 - 706
[3] POLYMORPHIC HYDROXYLATION OF PERHEXILINE-MALEATE IN MAN
COOPER, RG
EVANS, DAP
WHIBLEY, EJ
[J]. JOURNAL OF MEDICAL GENETICS, 1984, 21 (01) : 27 - 33
[4] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[5] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[6] IDLE JR, 1984, 2ND P WORLD C CLIN P, P148
[7] DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS
INABA, T
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 218 - 223
[8] LACK OF EVIDENCE FOR POLYMORPHISM IN METOPROLOL METABOLISM
JACK, DB
WILKINS, M
QUARTERMAN, CP
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) : 188 - 190
[9] JOHANSSON KA, 1974, ACTA PHARM SUEC, V11, P333
[10] OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE
LENNARD, MS
SILAS, JH
FREESTONE, S
RAMSAY, LE
TUCKER, GT
WOODS, HF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) : 1558 - 1560